Skip to main content
Top
Published in: Annals of Nuclear Medicine 1/2018

Open Access 01-01-2018 | Original Article

Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT

Authors: Mike Sathekge, Osvaldo Garcia-Perez, Diana Paez, Noura El-Haj, Taylor Kain-Godoy, Ismaheel Lawal, Enrique Estrada-Lobato

Published in: Annals of Nuclear Medicine | Issue 1/2018

Login to get access

Abstract

Objective

To determine the added value of CT over planar and SPECT-only imaging in the diagnosis of musculoskeletal infection using 99mTc-UBI 29-4.

Materials and methods

184 patients with suspected musculoskeletal infection who underwent planar and SPECT/CT imaging with 99mTc-UBI 29-41 were included. Planar, SPECT-only and SPECT/CT images were reviewed by two independent analysts for presence of bone or soft tissue infection. Final diagnosis was confirmed with tissue cultures, surgery/histology or clinical follow-up.

Results

99mTc-UBI 29-41 was true positive in 105/184 patients and true negative in 65/184 patients. When differentiating between soft tissue and bone infection, planar + SPECT-only imaging had a sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 95.0, 74.3, 84.8, 91.3 and 86.9%, respectively, versus 99.0, 94.5, 92.5, 98.5 and 94.5% for SPECT/CT. SPECT/CT resulted in a change in reviewers’ confidence in the final diagnosis in 91/184 patients. Inter-observer agreement was better with SPECT/CT compared with planar + SPECT imaging (kappa 0.87, 95% CI 0.71–0.85 versus kappa 0.81, 95% CI 0.58–0.75).

Conclusion

Addition of CT to planar and SPECT-only imaging led to an increase in diagnostic performance and an improvement in reviewers’ confidence and inter-observer agreement in differentiating bone from soft tissue infection.
Literature
1.
go back to reference Ferro-Flores G, Avila-Rodriguez MA, Garcia-Perez FO. Imaging of bacteria with radiolabeled ubiquicidin by SPECT and PET techniques. Clin Transl Imaging. 2016;4:175–82.CrossRef Ferro-Flores G, Avila-Rodriguez MA, Garcia-Perez FO. Imaging of bacteria with radiolabeled ubiquicidin by SPECT and PET techniques. Clin Transl Imaging. 2016;4:175–82.CrossRef
2.
go back to reference Lawal I, Zeevaart JR, Ebenhan T, Ankrah A, Vorster M, Kruger HG, et al. Metabolic imaging of infection. J Nucl Med. 2017;58:1727–32.CrossRefPubMed Lawal I, Zeevaart JR, Ebenhan T, Ankrah A, Vorster M, Kruger HG, et al. Metabolic imaging of infection. J Nucl Med. 2017;58:1727–32.CrossRefPubMed
3.
go back to reference Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S, et al. SPECT/CT using 67 Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587–94.PubMed Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S, et al. SPECT/CT using 67 Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587–94.PubMed
4.
go back to reference Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47:1908–13.PubMed Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47:1908–13.PubMed
5.
go back to reference Sepúlveda-Méndez J, de Murphy CA, Rojas-Bautista JC, Pedraza-López M. Specificity of 99mTc-UBI for detecting infection foci in patients with fever in study. Nucl Med Commun. 2010;31:889–95.PubMed Sepúlveda-Méndez J, de Murphy CA, Rojas-Bautista JC, Pedraza-López M. Specificity of 99mTc-UBI for detecting infection foci in patients with fever in study. Nucl Med Commun. 2010;31:889–95.PubMed
6.
go back to reference Roach PJ, Schembri GP, Ho Shon IA, Bailey EA, Bailey DL. SPECT/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl Med Commun. 2006;27:977–87.CrossRefPubMed Roach PJ, Schembri GP, Ho Shon IA, Bailey EA, Bailey DL. SPECT/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl Med Commun. 2006;27:977–87.CrossRefPubMed
7.
go back to reference Meléndez-Alafort L, Rodrìguez-Cortés J, Ferro-Flores G, Arteaga de Murphy C, Herrera-Rodriguez R, Mitsoura E, et al. Biokinetics of 99mTc-UBI in humans. Nucl Med Biol. 2004;31:373–9.CrossRefPubMed Meléndez-Alafort L, Rodrìguez-Cortés J, Ferro-Flores G, Arteaga de Murphy C, Herrera-Rodriguez R, Mitsoura E, et al. Biokinetics of 99mTc-UBI in humans. Nucl Med Biol. 2004;31:373–9.CrossRefPubMed
8.
go back to reference Jehangir M, Bashar M, Pervez S. Development of kits for 99mTc radiopharmaceuticals for infection imaging. IAEA-TECDOC-1414. 2004;65–77. Jehangir M, Bashar M, Pervez S. Development of kits for 99mTc radiopharmaceuticals for infection imaging. IAEA-TECDOC-1414. 2004;65–77.
9.
go back to reference Mikolajczak R, Korsak A, Gorska B, Markiewiz E, Zakrzewska W, Zulczyk U, et al. Development of kits for 99mTc radiopharmaceuticals for infection imaging. IAEA-TECDOC-1414. 2004;79–86. Mikolajczak R, Korsak A, Gorska B, Markiewiz E, Zakrzewska W, Zulczyk U, et al. Development of kits for 99mTc radiopharmaceuticals for infection imaging. IAEA-TECDOC-1414. 2004;79–86.
10.
go back to reference Akhtar MS, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Khan B, et al. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849–56.PubMed Akhtar MS, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Khan B, et al. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849–56.PubMed
11.
go back to reference Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CP, Lupetti A, Pauwels EK. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45:321–6.PubMed Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CP, Lupetti A, Pauwels EK. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45:321–6.PubMed
12.
go back to reference Signore A, D’Alessandria C, Lazzeri E, Dierckx R. Can we produce an image of bacteria with radiopharmaceuticals? Eur J Nucl Med Mol Imaging. 2008;35:1051–5.CrossRefPubMedPubMedCentral Signore A, D’Alessandria C, Lazzeri E, Dierckx R. Can we produce an image of bacteria with radiopharmaceuticals? Eur J Nucl Med Mol Imaging. 2008;35:1051–5.CrossRefPubMedPubMedCentral
13.
go back to reference Saeed S, Zafar J, Khan B, Akhtar A, Qurieshi S, Fatima S, et al. Utility of 99mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection. Eur J Nucl Med Mol Imaging. 2013;40:737–43.CrossRefPubMed Saeed S, Zafar J, Khan B, Akhtar A, Qurieshi S, Fatima S, et al. Utility of 99mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection. Eur J Nucl Med Mol Imaging. 2013;40:737–43.CrossRefPubMed
14.
go back to reference Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292–301.CrossRefPubMed Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292–301.CrossRefPubMed
15.
go back to reference Lupetti A, Welling MM, Pauwels EK, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis. 2003;3:223–9.CrossRefPubMed Lupetti A, Welling MM, Pauwels EK, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis. 2003;3:223–9.CrossRefPubMed
16.
go back to reference Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med. 2005;46:567–73.PubMed Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med. 2005;46:567–73.PubMed
17.
go back to reference Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42:788–94.PubMed Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42:788–94.PubMed
18.
go back to reference Arteaga de Murphy C, Gemmel F, Balter J. Clinical trial of specific imaging of infections. Nucl Med Commun. 2010;8:726–33. Arteaga de Murphy C, Gemmel F, Balter J. Clinical trial of specific imaging of infections. Nucl Med Commun. 2010;8:726–33.
19.
go back to reference Assadi M, Vahdat K, Nabipour I, Sehhat MR, Hadavand F, Javadi H, et al. Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging. Nucl Med Commun. 2011;32:716–23.CrossRefPubMed Assadi M, Vahdat K, Nabipour I, Sehhat MR, Hadavand F, Javadi H, et al. Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging. Nucl Med Commun. 2011;32:716–23.CrossRefPubMed
20.
go back to reference Akhtar MS, Khan ME, Khan B, Irfanullah J, Afzal MS, Khan MA, et al. An imaging analysis of (99 m)Tc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging. 2008;35:1056–64.CrossRefPubMed Akhtar MS, Khan ME, Khan B, Irfanullah J, Afzal MS, Khan MA, et al. An imaging analysis of (99 m)Tc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging. 2008;35:1056–64.CrossRefPubMed
21.
go back to reference Crudo J, Zapata A, Nevares N, Obanaus E, Castiglia SG de. In vitro and in vivo evaluation of 99mTc-labelled peptides for infection imaging. IAEA-TECDOC-1414. 2004;11–22. Crudo J, Zapata A, Nevares N, Obanaus E, Castiglia SG de. In vitro and in vivo evaluation of 99mTc-labelled peptides for infection imaging. IAEA-TECDOC-1414. 2004;11–22.
22.
go back to reference Widjaksana W, Yunita F, Andriastuti L, Ariyanto YA, Mondrida G, Roseliana A, et al. 99mTc labelling of ubiquicidine (UBI 29-41) and EDTA-biotin monomer (EB1). IAEA-TECDOC-1414. 2004;41–53. Widjaksana W, Yunita F, Andriastuti L, Ariyanto YA, Mondrida G, Roseliana A, et al. 99mTc labelling of ubiquicidine (UBI 29-41) and EDTA-biotin monomer (EB1). IAEA-TECDOC-1414. 2004;41–53.
23.
go back to reference Signore A, Glaudemans AW. The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med. 2011;25:681–700.CrossRefPubMed Signore A, Glaudemans AW. The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med. 2011;25:681–700.CrossRefPubMed
24.
go back to reference Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, et al. SPECT/CT. J Nucl Med. 2008;49:1305–19.CrossRefPubMed Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, et al. SPECT/CT. J Nucl Med. 2008;49:1305–19.CrossRefPubMed
25.
go back to reference Shinto AS, Mukherjee A, Karuppusamy KK, Joseph J, Bhatt J, Korde A, et al. Clinical utility of 99mTc-Ubiquicidin (29-41) as an adjunct to bone scan in differentiating infected versus non-infected loosening of prosthesis before revision surgery. Nucl Med Commun. 2017;38:285–90.CrossRefPubMed Shinto AS, Mukherjee A, Karuppusamy KK, Joseph J, Bhatt J, Korde A, et al. Clinical utility of 99mTc-Ubiquicidin (29-41) as an adjunct to bone scan in differentiating infected versus non-infected loosening of prosthesis before revision surgery. Nucl Med Commun. 2017;38:285–90.CrossRefPubMed
26.
go back to reference Ebenhan T, Zeevaart JR, Venter JD, Govender T, Kruger GH, Jarvis NV, et al. Preclinical evaluation of 68 Ga-labeled 1,4,7triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014;55:308–14.CrossRefPubMed Ebenhan T, Zeevaart JR, Venter JD, Govender T, Kruger GH, Jarvis NV, et al. Preclinical evaluation of 68 Ga-labeled 1,4,7triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014;55:308–14.CrossRefPubMed
27.
go back to reference Esmailiejah AK, Abbasian M, Azarsina S, Safdari F, Amoui M, Hosseinzadeh S. Diagnostic efficacy of UBI scan in Musculoskeletal infections. Arch Iran Med. 2015;18:371–5.PubMed Esmailiejah AK, Abbasian M, Azarsina S, Safdari F, Amoui M, Hosseinzadeh S. Diagnostic efficacy of UBI scan in Musculoskeletal infections. Arch Iran Med. 2015;18:371–5.PubMed
Metadata
Title
Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT
Authors
Mike Sathekge
Osvaldo Garcia-Perez
Diana Paez
Noura El-Haj
Taylor Kain-Godoy
Ismaheel Lawal
Enrique Estrada-Lobato
Publication date
01-01-2018
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 1/2018
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-017-1219-7

Other articles of this Issue 1/2018

Annals of Nuclear Medicine 1/2018 Go to the issue